Navigation Links
Inspire Announces Presentations at Two European Scientific,Conferences

DURHAM, N.C.--(BUSINESS WIRE)--Jun 12, 2007 - Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that scientists and collaborators related to Inspire will present information at the XXVI Congress of the European Academy of Allergology and Clinical Immunology (EAACI) being held June 9-13, 2007 in Goteborg, Sweden and at the 30th European Cystic Fibrosis Society (ECFS) Conference being held June 13-16, 2007 in Belek, Turkey.

The EAACI Congress includes two presentations with clinical data on bilastine, a compound in development by FAES Farma, S.A. for the treatment of allergic rhinitis, which is partnered with Inspire in the United States and Canada, and one presentation with scientific data on epinastine, bilastine and other antihistamines for treating allergies. -0-

-- A Phase 3 Study Comparing the Efficacy and Safety of Once Daily

   Bilastine with Cetirizine and Placebo for the Treatment of Seasonal

   Allergic Rhinitis

   Poster and brief oral presentation on Tuesday, June 12, 2007


-- Treatment with Bilastine Improves Symptoms in Patients with

   Seasonal Allergic Rhinitis (Phase 3 Study Comparing the Efficacy

   and Safety of Once Daily Bilastine with Desloratadine and Placebo

   for the Treatment of Seasonal Allergic Rhinitis)

   Poster and brief oral presentation on Tuesday, June 12, 2007


-- Evaluation of Muscarinic Receptor Antagonism by Antihistamines

   Poster and brief oral presentation on Tuesday, June 12, 2007

The ECFS Conference includes two presentations with clinical data on denufosol, a compound in development by Inspire for the treatment of cystic fibrosis. -0-

-- Deposition and Pharmacokinetic Studies with Inhaled P2Y2 Agonists -

   Evidence of High Lung Delivery and Minimal Systemic Exposure

   Poster presentation on Thursday and Friday, June 14-15, 2007 and

   oral presentation on Thursday, June 14, 2007


-- Reactive Airway Disease and
'"/>




Page: 1 2 3

Related medicine technology :

1. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis
3. Inspire Announces Presentations at 2007 Association for Research in Vision and Ophthalmology Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease

Post Your Comments:
(Date:11/20/2009)... Nov. 20 /PRNewswire-FirstCall/ -- Landauer, In...he fiscal fourth quarter and full year of 2009 pre...mpany will host a conference call for investors on...ime. Investors may access the live call by dialing...), or 480-629-9835 (international callers), or by ...
(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Pipettes & Pipettors - ...portlinker.com/p0164373/Pipettes--Pipettors---A-Gl...&utm_medium=pr&utm_campaign=prnewswire ,...gral part of any research laboratory. Large-scale ...
(Date:11/20/2009)... and LONDON, Nov. 20 Bos...nounced that it has received 510(k) clearance from...E Mark approval to market its WallFlex® Fully...ignant esophageal strictures (obstructions) caused...ctable esophageal cancer. ,, (Photo: http://...
Breaking Medicine Technology:Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Fruit juices contain more vitamin C than their labels indicate 58852 1Fruit juices contain more vitamin C than their labels indicate 58852 2Focused Radiation Protects Tumor Patients Brain Function 58850 1Focused Radiation Protects Tumor Patients Brain Function 58850 2Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 1Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 2Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 3Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 4
... (http://www.USPreventiveMedicine.com ) a company ...ctive preventive health services, announced today ...rvices, Inc., a national,provider of chronic condi...onville, Fla. Terms of the deal were not disclosed...leading-edge care,management programs will enable ...
...itoring Becomes Recommended and the Need for Accu... Microlife Manufactures the Only Home Blood Press...al-sclerosis in End Stage Renal Disease), DUNEDIN...Heart Association,s Recommendations for Blood Pres...and patients are recognizing the need to,accuratel...
Other Medicine Technology:U.S. Preventive Medicine Acquires Specialty Disease Management 2U.S. Preventive Medicine Acquires Specialty Disease Management 3U.S. Preventive Medicine Acquires Specialty Disease Management 4Microlife's Home Blood Pressure Monitors Proven Accurate Even for Critical Patients 2Microlife's Home Blood Pressure Monitors Proven Accurate Even for Critical Patients 3
(Date:11/20/2009)...ewswire-USNewswire/ -- The American Dental Associa...nistration (FDA) to establish appropriate classifi...ng concern about the safety of whitening products ... professional consultation or examination by a den... chemically based tooth whitening or bleaching age...
(Date:11/20/2009)...0 SIRIUS XM Radio (Nas...t Doctor Radio Reports: What Every Women Needs ...ted by veteran journalist Perri Peltz. ,, (Log...YTU044LOGO ) ,, Doctor Radio Reports: What E...r November 21 live at 10:00 am ET on Doctor Rad...
(Date:11/20/2009)...out of Dallas, TX, the new addition to blue sky sc...e made in the USA. , Aust...s is an independent medical scrubs brand which foc...and distribution of hospital uniforms and surgical...s via their online boutique, the Austin, TX busine...
(Date:11/20/2009)...me OB/GYN warns against the new breast cancer reco...ices Task Force. These guidelines may be cost-effe...When is it wrong to be safe than sorry? , ...s Task Force recommendations, published in the cur... set off a firestorm in the medical community. Maj...
(Date:11/20/2009).... 20 The Louisiana ...at Louisianians could experience higher health car... considered by Congress should become law. ,, A... LAHP, "Louisiana health plans have supported comp...f the national debate. Our plans have offered sig...
Breaking Medicine News(10 mins):Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2
...king research into treating malaria infections in ..., Director of the Wellcome Trust-funded Shoklo Mal...ternational recognition. Professor Nosten today re...veloping countries, presented by the Institut de F...
...lth Insurance Under Purina(R) Brand Is Comprehensi...Use, ST. LOUIS, June 11 Millions of pet owners c...ds and they want to provide them,with the best car...longer than ever before. Many medical advances onc...
...e 11 HMS Holdings Corp. (Nasdaq:,HMSY) today anno...,Healthcare Conference, which will be held June 24... Chief Financial Officer of HMS Holdings Corp.,wil...p://www.hmsholdings.com/news/presentations.asp . T...
...: For Dan Savage, surviving testicular cancer has...d taking more adventurous decisions, and he says, ...t things that has happened to him. But as he appro...ow on he will have no regular medical checks that ...
...s say that while police are using their resources ...asier to secure convictions for - the majority of ...ld are still avoiding prosecution. Currently only ...lnerable children open to unmonitored paedophile p...
...its weren,t limited to high-risk women, study find...-- A drug already approved to reduce the risk of b... the risk for other women. , A new analysis finds ...ancer, compared with women who did not take the dr...
Other Medicine News:Health News:Maternal malaria researcher wins prestigious international prize 2Health News:Maternal malaria researcher wins prestigious international prize 3Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 2Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 3Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 4Health News:Cancer was one of the best things to happen to me ... but I worry about the future 2Health News:Sex offenders register provides limited protection for children 2Health News:Raloxifene Cuts Risk of Certain Type of Breast Cancer 2
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: